Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
There will be gales across Scotland and northern England this morning, but these will gradually ease through the afternoon.
An unnamed 14-year-old boy was taken into custody following the attack, Anderson County Coroner Greg Shore said.
Scientists hope to capture stunning images and valuable data in the final moments before its impact.